Advertisement
| cannabis-induced psychosis case study: The Health Effects of Cannabis and Cannabinoids National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda, 2017-03-31 Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€that summarizes and prioritizes pressing research needs. |
| cannabis-induced psychosis case study: Marijuana and Madness David Castle, Robin Murray, 2004-05-27 This book provides a comprehensive overview of the psychiatry and neuroscience of Cannabis sativa (marijuana), with particular emphasis on psychotic disorders. It outlines developments in our understanding of the human cannabinoid system, and links this knowledge to clinical and epidemiological facts about the impact of cannabis on mental health. Clinically focused chapters review not only the direct psychomimetic properties of cannabis, but also the impact consumption has on the courses of evolving or established mental illness such as schizophrenia. A number of controversial issues are critically explored, including whether a discrete 'cannabis psychosis' exists, and whether cannabis can actually cause schizophrenia. Effects of cannabis on mood, notably depression, are reviewed, as are its effects on cognition. This book will be of interest to all members of the mental health team, as well as to neuroscientists and those involved in drug and alcohol research. |
| cannabis-induced psychosis case study: The Complex Connection between Cannabis and Schizophrenia Michael T. Compton, Marc Manseau, 2017-08-25 The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship. Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia. - Synthesizes existing knowledge about the confusing, but crucial, relationship between cannabis use and schizophrenia symptoms - Provides a comprehensive overview of the neurobiological mechanisms of cannabis use and its effects on the brain, including an exploration of the endocannabinoid system - Examines the promising evidence suggesting cannabidiol as an effective antipsychotic treatment for schizophrenia - Aids readers studying the neurobiological underpinning of cannabis addiction and psychosis in determining directions for their own future research |
| cannabis-induced psychosis case study: Tell Your Children Alex Berenson, 2020-02-18 In “a brilliant antidote to all the…false narratives about pot” (American Thinker), an award-winning author and former New York Times reporter reveals the link between teenage marijuana use and mental illness, and a hidden epidemic of violence caused by the drug—facts the media have ignored as the United States rushes to legalize cannabis. Recreational marijuana is now legal in nine states. Advocates argue cannabis can help everyone from veterans to cancer sufferers. But legalization has been built on myths—that marijuana arrests fill prisons; that most doctors want to use cannabis as medicine; that it can somehow stem the opiate epidemic; that it is beneficial for mental health. In this meticulously reported book, Alex Berenson, a former New York Times reporter, explodes those myths, explaining that almost no one is in prison for marijuana; a tiny fraction of doctors write most authorizations for medical marijuana, mostly for people who have already used; and marijuana use is linked to opiate and cocaine use. Most of all, THC—the chemical in marijuana responsible for the drug’s high—can cause psychotic episodes. “Alex Berenson has a reporter’s tenacity, a novelist’s imagination, and an outsider’s knack for asking intemperate questions” (Malcolm Gladwell, The New Yorker), as he ranges from the London institute that is home to the scientists who helped prove the cannabis-psychosis link to the Colorado prison where a man now serves a thirty-year sentence after eating a THC-laced candy bar and killing his wife. He sticks to the facts, and they are devastating. With the US already gripped by one drug epidemic, Tell Your Children is a “well-written treatise” (Publishers Weekly) that “takes a sledgehammer to the promised benefits of marijuana legalization, and cannabis enthusiasts are not going to like it one bit” (Mother Jones). |
| cannabis-induced psychosis case study: First Episode Psychosis Katherine J. Aitchison, Robin M. Murray, Patrick J. R. Power, Eva M. Tsapakis, 1999-02-17 The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. |
| cannabis-induced psychosis case study: Handbook of Cannabis and Related Pathologies Victor R Preedy, 2016-12-31 Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment is the first book to take an interdisciplinary approach to the understanding of cannabis use and misuse. Recent worldwide trends toward decriminalizing marijuana for medical use have increased legal use of the drug and recreational use remains high, making cannabis one of the most commonly used drugs. Cannabis has a wide range of adverse neurological effects, and use and abuse can lead to physical, social, and psychopathological issues that are multifarious and complex. Effective understanding and treatment requires knowledge of the drug's effects from across scientific disciplines. This book provides an overview of the biological and pharmacological components of the cannabis plant, outlines its neurological, social, and psychopathological effects, assists in the diagnosis and screening for use and dependency, and aids researchers in developing effective treatments for cannabis-related issues and disorders. Fully illustrated, with contributions from internationally recognized experts, it is the go-to resource for neuroscientists, pharmacologists, pathologists, public-health workers, and any other researcher who needs an in-depth and cross-disciplinary understanding of cannabis and its effects. - Comprehensive chapters include an abstract, key facts, mini dictionary of terms, and summary points - Presents illustrations with at least six figures, tables, and diagrams per chapter - Provides a one-stop-shopping synopsis of everything to do with cannabis and its related pathology, from chemicals and cells, individuals and communities, and diagnosis and treatment - Offers an integrated and informed synopsis of the complex issues surrounding cannabis as a substance, its use, and its misuse |
| cannabis-induced psychosis case study: Marijuana and Mental Health Michael T. Compton, M.D., M.P.H., 2016-03-18 With relatable clinical vignettes that illustrate the applicability of each chapter’s content, as well as key chapter points that summarize major themes, Marijuana and Mental Health is the definitive, single source of comprehensive information on marijuana and mental health in modern American society. Balanced, focused, and highly readable, chapters address topics such as the effects of marijuana on the brain and mind, marijuana-related policy and legislation, the complex link between marijuana use and psychotic disorders, synthetic cannabinoids, and the treatment and prevention of marijuana misuse. Beyond offering clinical and research psychiatrists, psychiatric residents and fellows, clinical psychologists, and psychiatric nurses a comprehensive but concise compilation of research in this area, this reference informs clinical mental health practice as well as policy decisions by articulating the connection between marijuana and mental health, particularly in the United States. |
| cannabis-induced psychosis case study: Clinical Cases in Psychiatry Paolo Brambilla, 2019 This case series book offers a practical and accessible approach to psychiatry, addressing major clinical problems ranging from psychosis to aging effects, each of which is tackled as it arises in everyday settings. With its emphasis on everyday practice strongly linked to underlying theory, the book combines clinical knowledge with the realities of managing clinical problems, and will provide a basis for developing sound analytical and confident decision-making skills. Presenting different visions of clinical psychiatry and expanding psychiatrists' interventions by integrating innovative neuroscience approaches such as neuroimaging, neuropsychology, TMS and cognitive rehabilitation, it will help clinicians and students alike gain a sound understanding of the wide range of signs and symptoms that indicate psychiatric disorders, and how the diagnosis, management and treatment options can differ from those in other medical specialties. The volume includes learning activities, with questions on each clinical case followed by detailed explanatory answers, and self-assessment exercises to assist with learning and revision. Throughout the book, tips and key features are highlighted with boxes, algorithms, tables and figures, which the reader can refer back to for exam revision and well into her/his career. |
| cannabis-induced psychosis case study: Therapeutic Uses of Cannabis British Medical Association, 2020-08-17 At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma. |
| cannabis-induced psychosis case study: The Effects of Drug Abuse on the Human Nervous System Bertha Madras, Michael Kuhar, 2013-11-15 Drug use and abuse continues to thrive in contemporary society worldwide and the instance and damage caused by addiction increases along with availability. The Effects of Drug Abuse on the Human Nervous System presents objective, state-of-the-art information on the impact of drug abuse on the human nervous system, with each chapter offering a specific focus on nicotine, alcohol, marijuana, cocaine, methamphetamine, MDMA, sedative-hypnotics, and designer drugs. Other chapters provide a context for drug use, with overviews of use and consequences, epidemiology and risk factors, genetics of use and treatment success, and strategies to screen populations and provide appropriate interventions. The book offers meaningful, relevant and timely information for scientists, health-care professionals and treatment providers. - A comprehensive reference on the effects of drug addiction on the human nervous system - Focuses on core drug addiction issues from nicotine, cocaine, methamphetamine, alcohol, and other commonly abused drugs - Includes foundational science chapters on the biology of addiction - Details challenges in diagnosis and treatment options |
| cannabis-induced psychosis case study: Handbook of Cannabis Roger G. Pertwee, 2014 In addition it also examines the complex morphology, cultivation, harvesting, and processing of cannabis and the ways in which the plant's chemical composition can be controlled. As well as offering a raft of scientific information there is extensive coverage of cannabinoid-based medicines. Helping readers to identify and evaluate their benefits, chapters explore pharmacological actions and the effects that seem to underlie approved therapeutic uses, how they are currently used to treat certain disorders, and the ever-growing number of wide-ranging potential clinical applications. There is also coverage of both the legal and illegal sources of cannabis, including 'coffee shops' and 'cannabis dispensaries'. The complex issue of 'recreational cannabis' is also tackled. |
| cannabis-induced psychosis case study: Psychosis with Coexisting Substance Misuse National Collaborating Centre for Mental Health (Great Britain), 2011 This text sets out clear recommendations for healthcare staff (based on the best available evidence) on how to assess and manage adults and young people (aged 14+) who have both psychosis and a substance misuse problem, in order to integrate treatment for both conditions and thus improve their care. |
| cannabis-induced psychosis case study: Camberwell Assessment of Need: Forensic Version Stuart Thomas, Mike Slade, 2021-04-29 The Camberwell Assessment of Need Forensic Version (CANFOR) is a tool for assessing the needs of people with mental health problems who are in contact with forensic services. It is based on the CAN, a widely used needs assessment for people with severe mental health problems. Individual needs are assessed in 25 areas of life, spanning health, social, clinical and functional domains. Comprehensive versions are available for research (CANFOR-R) and clinical use (CANFOR-C), as well as a short summary version (CANFOR-S) suitable for both research and clinical use. CANFOR was rigorously developed by a multidisciplinary team at the Institute of Psychiatry, London, and is suitable for use in all forensic mental health and prison settings. This second edition provides an update of the CANFOR tools and their application in clinical and research settings. The assessment forms are freely available to download from the CAN website (researchintorecovery.com/can) and cambridge.org. |
| cannabis-induced psychosis case study: Translational Neuroimaging Robert A. McArthur, 2012-10-26 This book covers methodical issues in human and animal neuroimaging translational research as well as detailed applied examples of the use of neuroimaging in neuropsychiatric disorders and the development of drugs for their treatment. Offering an accompanying website with illustrations and text available for further knowledge and presentations, Translational Neuroimaging: Tools for CNS Drug Discovery, Development and Treatment appeals to non-clinical and clinical neuroscientists working in and studying neuropsychiatric disorders and their treatment as well as providing the novice researcher or researcher outside of his/her expertise the opportunity to understand the background of translational research and the use of imaging in this field. Provides a background to translational research and the use of brain imaging in neuropsychiatric disorders. |
| cannabis-induced psychosis case study: Marijuana As Medicine? Institute of Medicine, Janet Joy, Alison Mack, 2000-12-30 Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€as well as the people who care for themâ€with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€in short, anyone who wants to learn more about this important issue. |
| cannabis-induced psychosis case study: Marijuana and Medicine Institute of Medicine, 1999-07-10 The medical use of marijuana is surrounded by a cloud of social, political, and religious controversy, which obscures the facts that should be considered in the debate. This book summarizes what we know about marijuana from evidence-based medicineâ€the harm it may do and the relief it may bring to patients. The book helps the reader understand not only what science has to say about medical marijuana but also the logic behind the scientific conclusions. Marijuana and Medicine addresses the science base and the therapeutic effects of marijuana use for medical conditions such as glaucoma and multiple sclerosis. It covers marijuana's mechanism of action, acute and chronic effects on health and behavior, potential adverse effects, efficacy of different delivery systems, analysis of the data about marijuana as a gateway drug, and the prospects for developing cannabinoid drugs. The book evaluates how well marijuana meets accepted standards for medicine and considers the conclusions of other blue-ribbon panels. Full of useful facts, this volume will be important to anyone interested in informed debate about the medical use of marijuana: advocates and opponents as well as policymakers, regulators, and health care providers. |
| cannabis-induced psychosis case study: Diagnosis, Management and Modeling of Neurodevelopmental Disorders Colin R Martin, Victor R Preedy, Rajkumar Rajendram, 2021-05-29 Diagnosis, Management and Modeling of Neurodevelopmental Disorders: The Neuroscience of Development is a comprehensive reference on the diagnosis and management of neurodevelopment and associated disorders. The book discusses the mechanisms underlying neurological development and provides readers with a detailed introduction to the neural connections and complexities in biological circuitries, as well as the interactions between genetics, epigenetics and other micro-environmental processes. In addition, the book also examines the pharmacological and non-pharmacological interventions of development-related conditions. - Provides the most comprehensive coverage of the broad range of topics relating to the neuroscience of aging - Features sections on the genetics that influences aging and diseases of aging - Contains an abstract, key facts, a mini dictionary of terms, and summary points in each chapter - Focuses on neurological diseases and conditions linked to aging, environmental factors and clinical recommendations - Includes more than 500 illustrations and tables |
| cannabis-induced psychosis case study: Hashish and Mental Illness Jacques Joseph Moreau, 1973 |
| cannabis-induced psychosis case study: Clinical Psychiatry Emil Kraepelin, Allen Ross Diefendorf, 1907 |
| cannabis-induced psychosis case study: The ICD-10 Classification of Mental and Behavioural Disorders World Health Organization, 1993-11 The content of Diagnostic criteria for research (DCR-10) is derived from chapter V(F), Mental and behavioural disorders, of ICD-10 [International Statistical Classification of Diseases and Related Health Problems, tenth revision] |
| cannabis-induced psychosis case study: Hallucinations in Psychoses and Affective Disorders Paolo Brambilla, Massimo Carlo Mauri, Alfredo Carlo Altamura, 2019-01-03 This book presents state of the art knowledge on the psychopathology, clinical symptomatology, biology, and treatment of hallucinations in patients with psychoses and affective disorders. The opening section describes and examines the origins of the hallucinatory symptoms associated with schizophrenia, bipolar disorders, and drug- or substance-induced psychoses. In addition, progress in understanding of hallucinations in children and adolescents and chronic hallucinatory disorder is reviewed, and the value of a Research Domain Criteria approach in elucidating the emergence of auditory hallucinations is explained. The biological basis of hallucinations is then closely scrutinized with reference to recent genetic research, neurochemical studies, and functional and structural neuroimaging data. Outcomes of a meta-analysis of diffusion tensor imaging studies regarding the association between white matter integrity and auditory verbal hallucinations are highlighted. The closing chapters focus on the roles of drug treatment and electric and magnetic brain stimulation techniques. The book will be of wide interest to psychiatrists and clinical psychologists. |
| cannabis-induced psychosis case study: Marijuana on My Mind Timmen Cermak, 2022-04-19 Scientific evidence makes sense of the increasingly polarised debate about the potential benefits and safety implications of cannabis use. |
| cannabis-induced psychosis case study: Cannabis Use and Dependence Wayne Hall, Rosalie Liccardo Pacula, 2003-11-28 The use of cannabis in the late twentieth and this century is an area of medical and moral controversy. Despite its illegality, cannabis is the most widely used drug after alcohol and tobacco among young adults in the USA, Europe and Australia. This book explores the relationship between health policy, public health and the law regarding cannabis use. It assesses the impact of illegality in drug use and relates this to policy analysis in Australia, the UK, the US and other developed societies. It evaluates debates about 'safe use' and 'harm minimisation' approaches, as well as examining the experiences of different prevention, treatment and education policies. Written by two leading drug advisors Cannabis Use and Dependence makes a valuable addition to this important field of research. |
| cannabis-induced psychosis case study: Ganja in Jamaica Vera Rubin, Lambros Comitas, 2019-05-20 No detailed description available for Ganja in Jamaica. |
| cannabis-induced psychosis case study: Social Cognition and Metacognition in Schizophrenia Paul Lysaker, Giancarlo Dimaggio, Martin Brüne, 2014-07-04 Deficits in social cognition and metacognition in schizophrenics makes it difficult for them to understand the speech, facial expressions and hence emotion and intention of others, as well as allowing little insight into their own mental state. These deficits are associated with poor social skills, fewer social relationships, and are predictive of poorer performance in a work setting. Social Cognition and Metacognition in Schizophrenia reviews recent research advances focusing on the precise nature of these deficits, when and how they manifest themselves, what their effect is on the course of schizophrenia, and how each can be treated. These deficits may themselves be why schizophrenia is so difficult to resolve; by focusing on the deficits, recovery may be quicker and long lasting. This book discusses such deficits in early onset, first episode, and prolonged schizophrenia; how the deficits relate to each other and to other forms of psychopathology; how the deficits affect social, psychological, and vocational functioning; and how best to treat the deficits in either individual or group settings. - Summarizes the types of social cognitive and metacognitive deficits present in schizophrenia - Discusses how deficits are related to each other and to other forms of psychopathology - Describes how deficits impact function and affect the recovery process - Provides treatment approaches for these deficits |
| cannabis-induced psychosis case study: Health and Social Effects of Nonmedical Cannabis Use (The) World Health Organization, 2016-03-15 Cannabis is globally the most commonly used psychoactive substance under international control. In 2013 an estimated 181.8 million people aged 15-64 years used cannabis for nonmedical purposes globally (UNODC 2015). There is an increasing demand for treatment for cannabis-use disorders and associated health conditions in high- and middle-income countries. This report focuses on nonmedical use of cannabis building on contributions from a broad range of experts and researchers from different parts of the world. It aims to present current knowledge on the impact of nonmedical cannabis use on health from its impact on brain development to its role in respiratory diseases. The potential medical utility of cannabis - including the pharmacology toxicology and possible therapeutic applications of the cannabis plant - is outside the scope of this report. |
| cannabis-induced psychosis case study: Cannabis and Cognitive Functioning Nadia Solowij, 1998-06-13 This book reviews the cognitive effects of cannabis and presents findings on the consequences of long-term use. |
| cannabis-induced psychosis case study: From Bud to Brain: A Psychiatrist's View of Marijuana Timmen L. Cermak, 2020-04-02 The trend toward liberalizing medical and recreational marijuana use is increasing the obligation on clinicians to provide useful information to the public. This book summarizes the science all healthcare professionals need to know in order to provide objective and relevant information to a variety of patients, from recreational and medicinal users to those who use regularly, and to adolescents and worried parents. The author brings two and a half decades of studying cannabinoid research, and over forty years' experience in psychiatric and addiction medicine practice, to shed light on the interaction between marijuana and the brain. Topics range from how marijuana produces pleasurable sensations, relaxation and novelty (the 'high'), to emerging medical uses, effects of regular use, addiction, and policy. Principles of motivational interviewing are outlined to help clinicians engage patients in meaningful, non-judgmental conversations about their experiences with marijuana. An invaluable guide for physicians, nurses, psychologists, therapists, and counsellors. |
| cannabis-induced psychosis case study: Cannabis and the Developing Brain Miriam Melis, Olivier J Manzoni, 2022-08-18 Marijuana is the most commonly used psychotropic drug in the United States, after alcohol. With the legalization and decriminalization of cannabis, momentum continues to build and propelled by the reduction of stigma associated to its consumption, there is growing concern regarding the long-term impact on brain function and behavior. Cannabis and the Developing Brain aims to provide comprehensive research on the effects of cannabis during neurodevelopment stages (i.e., perinatal and adolescent ages). This book introduces readers to vivo neural circuits, molecular and cellular mechanisms affected by cannabis exposure during three different temporal windows of brain vulnerability. Second, it offers a unique insight to shared neurobiological features of cannabinoid exposure during different developmental periods. Lastly, Cannabis and the Developing Brain determines the adverse impact of developmental cannabinoid exposure on specific cognition, emotion and behaviors. - Reviews exposure effects on different areas and circuits of the brain - Identifies effects of exposure at prenatal, perinatal, infant, and adolescent ages - Includes cannabis interaction with known genetic and environmental risk factors - Contains neurodevelopment and neuropsychiatric disorders associated with cannabis exposure |
| cannabis-induced psychosis case study: Depersonalization Mauricio Sierra, 2009-08-13 Depersonalization is a dissociative disorder, causing alteration in the perception or experience of the self and a detachment from reality. This is a fascinating and clinically relevant phenomenon neglected within psychiatry. Far from being a rare condition, it can be as prevalent as schizophrenia or bipolar disorder and frequently occurs in association with other neuropsychiatric conditions. This book is a review of depersonalization, dealing with the subject from a wide range of perspectives and covering historical, conceptual, clinical, trans-cultural, pharmacological and neurobiological factors. It discusses recent neuroimaging studies providing fresh insights into the condition and opening up new opportunities to manage the symptoms with pharmacologic and psychotherapeutic interventions. It will be relevant to psychiatrists and clinical psychologists, as well as primary care practitioners, neurologists and psychiatric nurses. |
| cannabis-induced psychosis case study: Novel Psychoactive Substances Ornella Corazza, Andres Roman-Urrestarazu, 2017-08-09 In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p ublic health. |
| cannabis-induced psychosis case study: The Psychosis-Risk Syndrome Thomas McGlashan, Barbara Walsh, Scott Woods, 2010-06-03 Using the authors' over thirteen years of experience at the psychosis-risk clinic at Yale University School of Medicine, The Psychosis-Risk Syndrome presents a concise handbook that details the diagnostic tools and building blocks that comprise the Structural Interview for Psychosis-Risk Syndromes, or SIPS. Clear and to the point, this volume provides an in-depth description of this new clinical high-risk population, along with instructions on how to use the SIPS to evaluate persons for psychosis-risk.The handbook's main section takes the reader step-by-step through the SIPS evaluation, tracking how patients and families find their way to the clinic, the initial interview, the evaluation process, and the summary session consisting of findings and future options. The core diagnostic symptoms of the SIPS and psychosis-risk states are illustrated with dozens of symptom and case examples drawn from real but disguised patients from the Yale clinic. With an emphasis on clinical usefulness, the handbook finishes with practice cases for the reader to test his or her new skills at evaluating clinical populations for psychosis-risk. |
| cannabis-induced psychosis case study: Memory Loss, Alzheimer's Disease, and Dementia Andrew E. Budson, Paul R. Solomon, 2015-05-20 Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices. |
| cannabis-induced psychosis case study: The Maudsley Guidelines on Advanced Prescribing in Psychosis Paul Morrison, David M. Taylor, Phillip McGuire, 2020-01-21 A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors – noted experts on the topic – offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans. The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource: Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis Offers a comparative strategy that helps gauge the suitability of one treatment plan over another Provides at-hand data and information about commonly used anti-psychotic drugs Includes an understanding of the origins and side-effects of each drug presented The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level. |
| cannabis-induced psychosis case study: Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders). Ana Adan, Marta Torrens, 2021 This book includes a compilation of papers published in 2020 and 2021 focused on dual disorders, which are found in significant and growing numbers in both substance addiction and mental health clinics. These contributions assume a broad perspective ranging from exposure to genetic and neurobiological elements to factors such as personality and quality of life. In all cases, these papers aimed to be transferred to and to benefit clinical practice. |
| cannabis-induced psychosis case study: The Healing Response Michael Loes, 2002 In this book, Dr. Loes details the Ten Principles and Laws of Healing and how to apply them. Also included are starter assessment tools and practical program tips. Finally, there are special sections on pain, healing wounds and fractures, irritable bowel syndrome, fatigue and headaches. The book follows a clear and logical pattern, and Dr. Loes applies his vast experience, and shows examples of how his applied principles can work for individual patients. Each principle is accompanied by a metaphor, which helps to explain the message Dr. Loes is communicating. |
| cannabis-induced psychosis case study: European Drug Report 2014 European Monitoring Centre for Drugs and Drug Addiction, 2014 |
| cannabis-induced psychosis case study: Case Studies: Stahl's Essential Psychopharmacology: Volume 3 Takesha Cooper, Gerald Maguire, Stephen Stahl, 2021-11-18 Following the success of the first two volumes in Stahl's Case Studies series, a brand new collection of clinical stories have been collated in Volume 3, derived from cases seen by medical students, residents and faculty from the University of California at Riverside (UCR) Department of Psychiatry and Neuroscience. The highly popular and unique user-friendly presentation of previous volumes has been maintained, with extensive use of icons, questions/answers, and tips. The cases address multifaceted issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life. |
| cannabis-induced psychosis case study: World Drug Report 2019 United Nations Office on Drugs and Crime, United Nations Office on Drugs and Crime (author), 1901 The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide. |
| cannabis-induced psychosis case study: Hallucinations in Psychoses and Affective Disorders Paolo Brambilla, Massimo Carlo Mauri, Alfredo Carlo Altamura, 2018-09-12 This book presents state of the art knowledge on the psychopathology, clinical symptomatology, biology, and treatment of hallucinations in patients with psychoses and affective disorders. The opening section describes and examines the origins of the hallucinatory symptoms associated with schizophrenia, bipolar disorders, and drug- or substance-induced psychoses. In addition, progress in understanding of hallucinations in children and adolescents and chronic hallucinatory disorder is reviewed, and the value of a Research Domain Criteria approach in elucidating the emergence of auditory hallucinations is explained. The biological basis of hallucinations is then closely scrutinized with reference to recent genetic research, neurochemical studies, and functional and structural neuroimaging data. Outcomes of a meta-analysis of diffusion tensor imaging studies regarding the association between white matter integrity and auditory verbal hallucinations are highlighted. The closing chapters focus on the roles of drug treatment and electric and magnetic brain stimulation techniques. The book will be of wide interest to psychiatrists and clinical psychologists. |
Cannabis - Wikipedia
Cannabis (/ ˈ k æ n ə b ɪ s / ⓘ) [2] is a genus of flowering plants in the family Cannabaceae that is widely accepted …
What Is Cannabis? Facts About Its Components, Effects, and …
Jun 22, 2023 · Read on to learn what cannabis is, and find a quick overview of its uses, legality, side effects, and …
Cannabis (Marijuana) | National Institute on Drug Ab…
Sep 24, 2024 · Cannabis, which some people call marijuana, refers to the dried leaves, flowers, stems, and …
Cannabis (Marijuana) and Cannabinoids: What You Nee…
Are marijuana and cannabis the same thing? What are cannabinoids? Can cannabis or cannabinoids treat …
Marijuana (Cannabis, Weed): What It Is, Side Effects & Risks
Nov 5, 2023 · Marijuana is a mind-alerting substance that comes from the Cannabis sativa plant. Other names …
Cannabis - Wikipedia
Cannabis (/ ˈ k æ n ə b ɪ s / ⓘ) [2] is a genus of flowering plants in the family Cannabaceae that is widely accepted as being indigenous to and originating from the continent of Asia. [3] [4] [5] …
What Is Cannabis? Facts About Its Components, Effects, and Hazards
Jun 22, 2023 · Read on to learn what cannabis is, and find a quick overview of its uses, legality, side effects, and more. As weed becomes legal in more areas, names for it are evolving.
Cannabis (Marijuana) | National Institute on Drug Abuse (NIDA)
Sep 24, 2024 · Cannabis, which some people call marijuana, refers to the dried leaves, flowers, stems, and seeds of the Cannabis sativa L plant. The plant contains at least 125 different …
Cannabis (Marijuana) and Cannabinoids: What You Need To Know
Are marijuana and cannabis the same thing? What are cannabinoids? Can cannabis or cannabinoids treat health conditions? Are they safe? Find out more here.
Marijuana (Cannabis, Weed): What It Is, Side Effects & Risks
Nov 5, 2023 · Marijuana is a mind-alerting substance that comes from the Cannabis sativa plant. Other names for it are weed, pot and dope. Learn about the many short-term and long-term …
Cannabis Health Effects | Cannabis and Public Health | CDC
Feb 16, 2024 · Cannabis is the most commonly used federally illegal drug in the United States, with an estimated 61.9 million people using it in 2022. 1 Cannabis use may have a wide range …
Cannabis: History, Types, Uses, Forms, Risks, Legality - Verywell …
Feb 6, 2021 · Cannabis is a family of plants with a myriad of uses from medicine to recreational use to bioplastics. Research has shown benefits, but also risks.
What are the health benefits and risks of cannabis? - Medical News Today
Jan 29, 2024 · Many people use cannabis to treat chronic pain, multiple sclerosis, and mental health conditions. However, research had identified both benefits and risks to using cannabis …
Cannabis: Uses (Medical), Effects & Warnings - Drugs.com
Cannabis, often smoked, is used for recreational or medical purposes. It is also referred to as grass, hashish, hemp, weed, marijuana and pot. In the U.S., it is still federally classified as …
CANNABIS - Uses, Side Effects, and More - WebMD
There are over 100 cannabinoids in cannabis, but THC and CBD are the most well-studied. Cannabinoids are found in the highest levels in the leaves and flowers of the plant. Cannabis is...
